BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
Quick Stats
Jan 30, 202653.0
AI Score
HOLD0.32
Volume Ratio
Mar 11, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
BCTX Stock Summary
Last updated Jan 30, 2026
BCTX is currently trading at $4.3, positioned below its 200-day moving average of $11.05, suggesting bearish momentum. The stock has a 52-week range of $0.61 to $98.2.
Technical Analysis: The 50-day moving average stands at $7.92, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.17, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.07, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BCTX at 53.0/100 with a HOLD recommendation.
BCTX (Briacell Therapeutics Corp. Common Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.17 |
| CMF (20) | -0.07 |
| ROC (10) | -4.232 |
| ADX (14) | 14.841 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.144 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -97.5 |
| MFI (14) | 68.746 |
BCTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BCTX Price vs Max Options Open Interest
BCTX Max Change In Options Open Interest
BCTX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BCTX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BCTX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BCTX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Briacell Therapeutics Corp. Common Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BCTX Moving Averages Analysis
BCTX (Briacell Therapeutics Corp. Common Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 4.44 |
| 20 | 5.8 |
| 30 | 6.58 |
| 50 | 7.92 |
| 100 | 9.4 |
| 200 | 11.05 |
BCTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 26.8 million |
| Earnings/Share ($) | -33.87 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -11.45 |
| EPS Estimate Next Year ($) | -3.4 |
| WallStreet Target Price ($) | 150 |
| Most Recent Quarter |